Skip to main content
. 2019 Mar 8;9:3967. doi: 10.1038/s41598-019-40692-6

Table 3.

Demographic, clinical, and laboratory data in diabetes and non-diabetes patients on peritoneal dialysis.

Diabetes group Non-diabetes group P-value
Patients (n) 3,319 5,635
Age (years) 63.9 ± 11.8 61.9 ± 13.6 <0.0001
Male sex (%) 70.4 59.9 <0.0001
PD duration (m) 26 [13–48] 37 [17–69] <0.0001
Type 1 diabetes (%) 8.3
Body mass index (kg/m2) 24.3 ± 3.8 22.7 ± 3.6 <0.0001
Smoking (%) 9.9 6.9 <0.0001
Antihypertensive agents (%) 81.7 77.5 <0.0001
Comorbid CVD (%) 21.4 11.3 <0.0001
Albumin (g/dL) 3.2 ± 0.5 3.3 ± 0.5 <0.0001
Non-HDL cholesterol (mg/dL) 126 ± 38 130 ± 36 0.004
HDL cholesterol (mg/dL) 46 ± 16 52 ± 17 <0.0001
HbA1c (%) 6.2 ± 1.1
C-reactive protein (mg/dL) 0.17 [0.09–0.49] 0.11 [0.06–0.37] 0.001
Calcium (mg/dL) 8.6 ± 0.8 8.8 ± 0.8 <0.0001
Phosphate (mg/dL) 5.2 ± 1.3 5.3 ± 1.3 0.028
Intact PTH (pg/mL) 150 [77–249] 158 [82–267] 0.002
Hemoglobin (g/dL) 10.8 ± 1.4 10.8 ± 1.4 0.313
Renal Kt/V 0.4 [0–0.9] 0.2 [0–0.7] <0.0001
PD Kt/V 1.3 ± 0.6 1.4 ± 0.6 <0.0001
Total Kt/V 1.8 ± 0.8 1.8 ± 0.8 0.848
D/P Cr 0.67 ± 0.13 0.64 ± 0.13 <0.0001
PET category (%) <0.0001
   Low 8.1 11.6
   Low average 36.7 39.1
   High average 42.1 40.5
   High 13.1 8.8
Use of 2.5% glucose dialysate (%) 40.1 36.0 0.002
Use of icodextrin (%) 45.0 38.3 <0.0001
Use of APD system (%) 43.3 43.1 0.924
Connecting system (%)
   Device (+) 72.5 65.5 <0.001
PD + HD combination (%) 18.5 19.0 0.537

Data are shown as the number, percentage, mean ± standard deviation, or median [interquartile range]. APD, automated peritoneal dialysis; Cr, creatinine; CVD, cardiovascular disease; D/P, dialysate/plasma; HD, hemodialysis; HDL, high-density lipoprotein; PD, peritoneal dialysis; PET, peritoneal equilibration test; PTH, parathyroid hormone.